{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:02:28Z","timestamp":1790290948600,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union's Horizon 2020 research and innovation programme under the Marie Sk\u0142odowska-Curie Grant Agreement","award":["No 101034324"],"award-info":[{"award-number":["No 101034324"]}]},{"DOI":"10.13039\/501100002661","name":"Fonds de la Recherche Scientifique","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Fondation Jaumotte-Demoulin"},{"name":"Walloon Region through the Technology Platforms of Excellence: \u2018Alternative to animal experimentation\u2019 and \u2018Biogreen\u2019"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04022-z","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:14:29Z","timestamp":1769786069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glutathione responsive iNOS inhibiting polymeric prodrug for targeted Inhibition of angiogenesis"],"prefix":"10.1186","volume":"24","author":[{"given":"Houman","family":"Alimoradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Jespers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargis","family":"Bolaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Townley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"T\u00f6rnroth-Horsefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Shavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dewachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Delporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"4022_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"Z-L Liu","year":"2023","unstructured":"Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Therapy. 2023;8:198.","journal-title":"Signal Transduct Target Therapy"},{"key":"4022_CR2","doi-asserted-by":"publisher","first-page":"rv114113","DOI":"10.1126\/scitranslmed.3003149","volume":"3","author":"Y Cao","year":"2011","unstructured":"Cao Y, Arbiser J, D\u2019Amato RJ, D\u2019Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B. Forty-year journey of angiogenesis translational research. Sci Transl Med. 2011;3:rv114113\u2013114113.","journal-title":"Sci Transl Med"},{"key":"4022_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008;8:592\u2013603.","journal-title":"Nat Rev Cancer"},{"key":"4022_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cells8091102","volume":"8","author":"J J\u00e1szai","year":"2019","unstructured":"J\u00e1szai J, Schmidt MH. Trends and challenges in tumor anti-angiogenic therapies. Cells. 2019;8:1102.","journal-title":"Cells"},{"key":"4022_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1006431309841","volume":"50","author":"M Ziche","year":"2000","unstructured":"Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol. 2000;50:139\u201348.","journal-title":"J Neurooncol"},{"key":"4022_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/2211738507666190429111306","volume":"7","author":"H Alimoradi","year":"2019","unstructured":"Alimoradi H, Greish K, Gamble AB, Giles GI. Controlled delivery of nitric oxide for cancer therapy. Pharm Nanatechnol. 2019;7:279\u2013303.","journal-title":"Pharm Nanatechnol"},{"key":"4022_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2019.10.411","volume":"146","author":"S Anavi","year":"2020","unstructured":"Anavi S, Tirosh O. iNOS as a metabolic enzyme under stress conditions. Free Radic Biol Med. 2020;146:16\u201335.","journal-title":"Free Radic Biol Med"},{"key":"4022_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1006\/bbrc.1998.9719","volume":"252","author":"J Kroll","year":"1998","unstructured":"Kroll J, Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun. 1998;252:743\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"4022_CR9","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.CIR.0000093190.53478.78","volume":"108","author":"T Namba","year":"2003","unstructured":"Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 2003;108:2250\u20137.","journal-title":"Circulation"},{"key":"4022_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jconrel.2015.09.019","volume":"217","author":"S Kudo","year":"2015","unstructured":"Kudo S, Nagasaki Y. A novel nitric oxide-based anticancer therapeutics by macrophage-targeted Poly (l-arginine)-based nanoparticles. J Controlled Release. 2015;217:256\u201362.","journal-title":"J Controlled Release"},{"key":"4022_CR11","doi-asserted-by":"publisher","first-page":"W324","DOI":"10.1093\/nar\/gkae300","volume":"52","author":"M Bugnon","year":"2024","unstructured":"Bugnon M, R\u00f6hrig UF, Goullieux M, Perez MA, Daina A, Michielin O, Zoete V. SwissDock 2024: major enhancements for small-molecule Docking with attracting cavities and AutoDock Vina. Nucleic Acids Res. 2024;52:W324\u201332.","journal-title":"Nucleic Acids Res"},{"key":"4022_CR12","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1021\/acs.jcim.3c00054","volume":"63","author":"UF R\u00f6hrig","year":"2023","unstructured":"R\u00f6hrig UF, Goullieux M, Bugnon M, Zoete V. Attracting cavities 2.0: improving the flexibility and robustness for small-molecule Docking. J Chem Inf Model. 2023;63:3925\u201340.","journal-title":"J Chem Inf Model"},{"key":"4022_CR13","doi-asserted-by":"publisher","first-page":"116580","DOI":"10.1016\/j.lfs.2019.116580","volume":"231","author":"A Hanthazi","year":"2019","unstructured":"Hanthazi A, Jespers P, Vegh G, Degroot G-N, Springael J-Y, Lybaert P, Dewachter L, Mc Entee K. Chemerin influences endothelin-and serotonin-induced pulmonary artery vasoconstriction in rats. Life Sci. 2019;231:116580.","journal-title":"Life Sci"},{"key":"4022_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.eurpolymj.2016.06.003","volume":"81","author":"I Insua","year":"2016","unstructured":"Insua I, Wilkinson A, Fernandez-Trillo F. Polyion complex (PIC) particles: Preparation and biomedical applications. Eur Polymer J. 2016;81:198\u2013215.","journal-title":"Eur Polymer J"},{"key":"4022_CR15","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3390\/polym16131871","volume":"16","author":"X Ma","year":"2024","unstructured":"Ma X, Zhao T, Ren X, Lin H, He P. Recent progress in polyion complex nanoparticles with enhanced stability for drug delivery. Polymers. 2024;16:1871.","journal-title":"Polymers"},{"key":"4022_CR16","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.drudis.2017.06.008","volume":"22","author":"VS Meka","year":"2017","unstructured":"Meka VS, Sing MK, Pichika MR, Nali SR, Kolapalli VR, Kesharwani P. A comprehensive review on polyelectrolyte complexes. Drug Discovery Today. 2017;22:1697\u2013706.","journal-title":"Drug Discovery Today"},{"key":"4022_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1021\/bc049743q","volume":"16","author":"T Merdan","year":"2005","unstructured":"Merdan T, Kunath K, Petersen H, Bakowsky U, Voigt KH, Kopecek J, Kissel T. PEGylation of Poly (ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjug Chem. 2005;16:785\u201392.","journal-title":"Bioconjug Chem"},{"key":"4022_CR18","doi-asserted-by":"publisher","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L, Zhang J, Zhao M, Tang S, Cheng X, Zhang W, Li W, Liu X, Peng H, Wang Q. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale. 2021;13:10748\u201364.","journal-title":"Nanoscale"},{"key":"4022_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","volume":"17","author":"MP Gamcsik","year":"2012","unstructured":"Gamcsik MP, Kasibhatla MS, Teeter SD, Colvin OM. Glutathione levels in human tumors. Biomarkers. 2012;17:671\u201391.","journal-title":"Biomarkers"},{"key":"4022_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/1097-0142(19930801)72:3<783::AID-CNCR2820720325>3.0.CO;2-U","volume":"72","author":"RR Perry","year":"1993","unstructured":"Perry RR, Mazetta J, Levin M, Barranco SC. Glutathione levels and variability in breast tumors and normal tissue. Cancer. 1993;72:783\u20137.","journal-title":"Cancer"},{"key":"4022_CR21","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1021\/cr300358b","volume":"113","author":"MH Lee","year":"2013","unstructured":"Lee MH, Yang Z, Lim CW, Lee YH, Dongbang S, Kang C, Kim JS. Disulfide-cleavage-triggered chemosensors and their biological applications. Chem Rev. 2013;113:5071\u2013109.","journal-title":"Chem Rev"},{"key":"4022_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acsnano.8b06400","volume":"13","author":"X Ling","year":"2018","unstructured":"Ling X, Tu J, Wang J, Shajii A, Kong N, Feng C, Zhang Y, Yu M, Xie T, Bharwani Z. Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy. ACS Nano. 2018;13:357\u201370.","journal-title":"ACS Nano"},{"key":"4022_CR23","doi-asserted-by":"publisher","first-page":"896136","DOI":"10.3389\/fcell.2022.896136","volume":"10","author":"X Wu","year":"2022","unstructured":"Wu X, Yu R, Yang M, Hu Y, Tang M, Zhang S, Abudourousuli A, Li X, Li Z, Liao X. Integrated analysis of glutathione metabolic pathway in pancreatic cancer. Front Cell Dev Biology. 2022;10:896136.","journal-title":"Front Cell Dev Biology"},{"key":"4022_CR24","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/1097-0142(20001001)89:7<1440::AID-CNCR5>3.0.CO;2-0","volume":"89","author":"T Schnelldorfer","year":"2000","unstructured":"Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth Inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer: Interdisciplinary Int J Am Cancer Soc. 2000;89:1440\u20137.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"key":"4022_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jn\/134.3.489","volume":"134","author":"G Wu","year":"2004","unstructured":"Wu G, Lupton JR, Turner ND, Fang Y-Z, Yang S. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489\u201392.","journal-title":"J Nutr"},{"key":"4022_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/6675","volume":"6","author":"TO Fischmann","year":"1999","unstructured":"Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999;6:233\u201342.","journal-title":"Nat Struct Biol"},{"key":"4022_CR27","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1021\/bi970331x","volume":"36","author":"R Gachhui","year":"1997","unstructured":"Gachhui R, Ghosh DK, Wu C, Parkinson J, Crane BR, Stuehr DJ. Mutagenesis of acidic residues in the Oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding. Biochemistry. 1997;36:5097\u2013103.","journal-title":"Biochemistry"},{"key":"4022_CR28","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1021\/bi500561h","volume":"53","author":"H Li","year":"2014","unstructured":"Li H, Jamal J, Delker S, Plaza C, Ji H, Jing Q, Huang H, Kang S, Silverman RB, Poulos TL. The mobility of a conserved tyrosine residue controls isoform-dependent enzyme\u2013inhibitor interactions in nitric oxide synthases. Biochemistry. 2014;53:5272\u20139.","journal-title":"Biochemistry"},{"key":"4022_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3389\/fonc.2020.00723","volume":"10","author":"B Daher","year":"2020","unstructured":"Daher B, Vu\u010deti\u0107 M, Pouyss\u00e9gur J. Cysteine depletion, a key action to challenge cancer cells to ferroptotic cell death. Front Oncol. 2020;10:723.","journal-title":"Front Oncol"},{"key":"4022_CR30","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1158\/1078-0432.CCR-05-2085","volume":"12","author":"A Yano","year":"2006","unstructured":"Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res. 2006;12:3003\u20139.","journal-title":"Clin Cancer Res"},{"key":"4022_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4067\/S0716-97602010000300008","volume":"43","author":"O Garrido","year":"2010","unstructured":"Garrido O, Letelier R, Rosas C, Fuenzalida M, Ferreira A, Lemus D. Betamethasone inhibits tumor development, microvessel density and prolongs survival in mice with a multiresistant adenocarcinoma TA3. Biol Res. 2010;43:317\u201322.","journal-title":"Biol Res"},{"key":"4022_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.018","volume":"296","author":"L Luo","year":"2019","unstructured":"Luo L, Yang J, Oh Y, Hartsock MJ, Xia S, Kim Y-C, Ding Z, Meng T, Eberhart CG, Ensign LM. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. J Controlled Release. 2019;296:68\u201380.","journal-title":"J Controlled Release"},{"key":"4022_CR33","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1021\/acs.macromol.3c01223","volume":"56","author":"AM Weiss","year":"2023","unstructured":"Weiss AM, Lopez MA, Rawe BW, Manna S, Chen Q, Mulder EJ, Rowan SJ, Esser-Kahn AP. Understanding how cationic polymers\u2019 properties inform toxic or Immunogenic responses via parametric analysis. Macromolecules. 2023;56:7286\u201399.","journal-title":"Macromolecules"},{"key":"4022_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M Guha","year":"2001","unstructured":"Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85\u201394.","journal-title":"Cell Signal"},{"key":"4022_CR35","doi-asserted-by":"publisher","unstructured":"Arita NO, Cohen MF, Tokuda G, Yamasaki H. Fluorometric detection of nitric oxide with diaminofluoresceins (DAFs): applications and limitations for plant NO research. Fluorometric detection of nitric oxide with diaminofluoresceins (DAFs): applications and limitations for plant NO research. Fluorometric detection of nitric oxide with diaminofluoresceins (DAFs): applications and limitations for plant NO research. Nitric Oxide Plant Growth Dev Stress Physiol. 2006:269\u2013280. https:\/\/doi.org\/10.1007\/7089_2006_090","DOI":"10.1007\/7089_2006_090"},{"key":"4022_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/pr.2012.9","volume":"71","author":"Y Pang","year":"2012","unstructured":"Pang Y, Fan L-W, Zheng B, Campbell LR, Cai Z, Rhodes PG. Dexamethasone and betamethasone protect against lipopolysaccharide-induced brain damage in neonatal rats. Pediatr Res. 2012;71:552\u20138.","journal-title":"Pediatr Res"},{"key":"4022_CR37","doi-asserted-by":"publisher","first-page":"35887","DOI":"10.1074\/jbc.M112.365171","volume":"287","author":"RS Chanthaphavong","year":"2012","unstructured":"Chanthaphavong RS, Loughran PA, Lee TY, Scott MJ, Billiar TR. A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) \u03b1-converting enzyme (TACE\/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes. J Biol Chem. 2012;287:35887\u201398.","journal-title":"J Biol Chem"},{"key":"4022_CR38","doi-asserted-by":"publisher","first-page":"15677","DOI":"10.1074\/jbc.M113.475319","volume":"288","author":"M Lee","year":"2013","unstructured":"Lee M, Choy JC. Positive feedback regulation of human inducible nitric-oxide synthase expression by Ras protein S-nitrosylation. J Biol Chem. 2013;288:15677\u201386.","journal-title":"J Biol Chem"},{"key":"4022_CR39","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-22-2791","volume":"29","author":"TP Reddy","year":"2023","unstructured":"Reddy TP, Glynn SA, Billiar TR, Wink DA, Chang JC. Targeting nitric oxide: say NO to metastasis. Clin Cancer Res. 2023;29:1855\u201368.","journal-title":"Clin Cancer Res"},{"key":"4022_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/0008-5472.CAN-13-0588","volume":"74","author":"E Lopez-Rivera","year":"2014","unstructured":"Lopez-Rivera E, Jayaraman P, Parikh F, Davies MA, Ekmekcioglu S, Izadmehr S, Milton DR, Chipuk JE, Grimm EA, Estrada Y. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2. Cancer Res. 2014;74:1067\u201378.","journal-title":"Cancer Res"},{"key":"4022_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13402-016-0287-3","volume":"39","author":"V Saisongkorh","year":"2016","unstructured":"Saisongkorh V, Maiuthed A, Chanvorachote P. Nitric oxide increases the migratory activity of non-small cell lung cancer cells via AKT-mediated integrin \u03b1v and \u03b21 upregulation. Cell Oncol. 2016;39:449\u201362.","journal-title":"Cell Oncol"},{"key":"4022_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18388\/abp.2003_3713","volume":"50","author":"H Kimura","year":"2003","unstructured":"Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol. 2003;50:49\u201359.","journal-title":"Acta Biochim Pol"},{"key":"4022_CR43","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3390\/ijms20123010","volume":"20","author":"P Palumbo","year":"2019","unstructured":"Palumbo P, Lombardi F, Augello FR, Giusti I, Luzzi S, Dolo V, Cifone MG, Cinque B. NOS2 inhibitor 1400\u00a0W induces autophagic flux and influences extracellular vesicle profile in human glioblastoma U87MG cell line. Int J Mol Sci. 2019;20:3010.","journal-title":"Int J Mol Sci"},{"key":"4022_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4022_CR45","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1038\/s41467-022-30063-7","volume":"13","author":"JR van Beijnum","year":"2022","unstructured":"van Beijnum JR, Huijbers EJ, van Loon K, Blanas A, Akbari P, Roos A, Wong TJ, Denisov SS, Hackeng TM, Jimenez CR. Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy. Nat Commun. 2022;13:2842.","journal-title":"Nat Commun"},{"key":"4022_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41388-020-01539-x","volume":"40","author":"D Kong","year":"2021","unstructured":"Kong D, Zhou H, Neelakantan D, Hughes CJ, Hsu JY, Srinivasan RR, Lewis MT, Ford HL. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene. 2021;40:964\u201379.","journal-title":"Oncogene"},{"key":"4022_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2010.10.001","volume":"24","author":"B Bonavida","year":"2011","unstructured":"Bonavida B, Baritaki S. Dual role of NO donors in the reversal of tumor cell resistance and EMT: downregulation of the NF-\u03baB\/Snail\/YY1\/RKIP circuitry. Nitric Oxide. 2011;24:1\u20137.","journal-title":"Nitric Oxide"},{"key":"4022_CR48","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1038\/s41467-024-54651-x","volume":"15","author":"T Reddy","year":"2024","unstructured":"Reddy T, Puri A, Guzman-Rojas L, Thomas C, Qian W, Zhou J, Zhao H, Mahboubi B, Oo A, Cho Y-J. NOS Inhibition sensitizes metaplastic breast cancer to PI3K Inhibition and taxane therapy via c-JUN repression. Nat Commun. 2024;15:10737.","journal-title":"Nat Commun"},{"key":"4022_CR49","doi-asserted-by":"crossref","unstructured":"Ponce ML. Tube formation: an in vitro matrigel angiogenesis assay. In Angiogenesis protocols. Springer; 2009: 183\u2013188.","DOI":"10.1007\/978-1-59745-241-0_10"},{"key":"4022_CR50","doi-asserted-by":"publisher","first-page":"104026","DOI":"10.1016\/j.mvr.2020.104026","volume":"131","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Annese T, Tamma R. The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials. Microvasc Res. 2020;131:104026.","journal-title":"Microvasc Res"},{"key":"4022_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00018-021-04042-y","volume":"79","author":"TL Smith","year":"2022","unstructured":"Smith TL, Oubaha M, Cagnone G, Boscher C, Kim JS, El Bakkouri Y, Zhang Y, Chidiac R, Corriveau J, Delisle C. eNOS controls angiogenic sprouting and retinal neovascularization through the regulation of endothelial cell Polarity. Cell Mol Life Sci. 2022;79:37.","journal-title":"Cell Mol Life Sci"},{"key":"4022_CR52","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.3748\/wjg.v11.i25.3830","volume":"11","author":"G-Y Wang","year":"2005","unstructured":"Wang G-Y, Ji B, Wang X, Gu J-H. Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J Gastroenterology: WJG. 2005;11:3830.","journal-title":"World J Gastroenterology: WJG"},{"key":"4022_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.niox.2018.12.008","volume":"83","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zhou S, Xu Y, Sheng S, Qian SY, Huo X. Nitric oxide synthase inhibitors 1400\u00a0W and L-NIO inhibit angiogenesis pathway of colorectal cancer. Nitric Oxide. 2019;83:33\u20139.","journal-title":"Nitric Oxide"},{"key":"4022_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/0003319720979243","volume":"72","author":"T Infante","year":"2021","unstructured":"Infante T, Costa D, Napoli C. Novel insights regarding nitric oxide and cardiovascular diseases. Angiology. 2021;72:411\u201325.","journal-title":"Angiology"},{"key":"4022_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/ars.2013.5244","volume":"20","author":"S Lankhorst","year":"2014","unstructured":"Lankhorst S, Kappers MH, van Esch JH, Danser AJ, van den Meiracker AH. Hypertension during vascular endothelial growth factor inhibition: focus on nitric oxide, endothelin-1, and oxidative stress. Antioxid Redox Signal. 2014;20:135\u201345.","journal-title":"Antioxid Redox Signal"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04022-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:59:42Z","timestamp":1772024382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4022"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04022-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}